Integration of telemedicine into clinical practice for inflammatory bowel disease.
Journal
Current opinion in gastroenterology
ISSN: 1531-7056
Titre abrégé: Curr Opin Gastroenterol
Pays: United States
ID NLM: 8506887
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
14
5
2020
medline:
16
10
2021
entrez:
14
5
2020
Statut:
ppublish
Résumé
In the context of the rising incidence and complexity of inflammatory bowel disease (IBD), telehealth offers new ways to support remote and efficient delivery of healthcare services. The aim of this review is to assess the current status of telehealth services in the management of IBD and challenges to adopting telehealth in clinical practice. Different modalities of telehealth such as virtual clinics and remote patient monitoring have been studied in many IBD centers. They are found to be associated with high patient acceptance, decreased healthcare costs, improved quality of life, treatment adherence, and disease knowledge among patients. The major challenges encountered in the integration of telemedicine into clinical practice include risks to patient privacy and confidentiality, requirement for informed consent, lack of uniform reimbursement policies, operational difficulties, provider acceptance, and licensing. Telehealth is an effective, efficient, and low-cost intervention that can address increasingly complex care of patients with IBD. However, for telemedicine to be adopted widely, new policies and reforms need to reduce the burden of physician licensing in multiple states, allow for receipt of all telehealth services in the patient's home or office, and require reimbursement for services on par with an office visit.
Identifiants
pubmed: 32398568
doi: 10.1097/MOG.0000000000000647
pii: 00001574-202007000-00009
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-309Références
Dahlhamer JM, Zammitti EP, Ward BW, et al. Prevalence of inflammatory bowel disease among adults aged ≥18 years—United States, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:1166–1169.
Aguas M, Del Hoyo J, Faubel R, Nos P. Telemedicine in inflammatory bowel disease: opportunity ahead. Inflamm Bowel Dis 2016; 22:E4–E5.
Centers for Medicare and Medicaid Services. Telemedicine. Available at: https://www.medicaid.gov/medicaid/benefits/telemed/index.html (accessed Feb. 17, 2020).
Health Resources and Services Administration. Telehealth. Available at: https://www.hrsa.gov/ruralhealth/telehealth/index.html (accessed Feb. 17, 2020).
Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis 2015; 21:392–399.
Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach. Gut 2010; 59:1652–1661.
Pedersen N, Thielsen P, Martinsen L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis 2014; 20:2276–2285.
Del Hoyo J, Nos P, Faubel R, et al. A web-based telemanagement system for improving disease activity and quality of life in patients with complex inflammatory bowel disease: pilot randomized controlled trial. J Med Internet Res 2018; 20:e11602.
Price T, Lithgo K, Johnson MW. PWE-062: The outcomes and benefits of moving stable inflammatory bowel disease patients from a paper based self management system to a supported, self-help and management programme (IBD-SSHAMP) with specialist overview; 2015.
Li SX, Thompson KD, Peterson T, et al. Delivering high value inflammatory bowel disease care through telemedicine visits. Inflamm Bowel Dis 2017; 23:1678–1681.
Ruf B, Jenkinson P, Armour D, et al. Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting. J Telemed Telecare 2019; 1357633X19849280.
Cross RK, Langenberg P, Regueiro M, et al. A randomized controlled trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol 2019; 114:472–482.
de Jong MJ, van der Meulen-de AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet 2017; 390:959–968.
Cross RL Jr, Kornak J, Burton A, Zubrow M. Implementation of telehealth visits in a tertiary referral center. American College of Gastroenterology 2016 Annual Scientific Meeting, Las Vegas, NV. 2016.
Kosinski L, Click B, Anderson A, et al. Project Sonar: reduction in cost of care in an attributed cohort of patients with Crohn's disease. Gastroenterology 2016; 150:S173.
Singh S, Brill JV, Proudfoot JA, et al. Project Sonar: a community practice-based intensive medical home for patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2018; 16:1847–1850.
Yin AL, Hachuel D, Pollak JP, et al. Digital health apps in the clinical care of inflammatory bowel disease: scoping review. J Med Internet Res 2019; 21:e14630.
Federation of State Medical Boards. Model policy for the appropriate use of telemedicine technologies in the practice of medicine, 2014.
Hall JL, McGraw D. For telehealth to succeed, privacy and security risks must be identified and addressed. Health Affairs 2014; 33:216–221.
Zubrow MT, Witzke AK, Reynolds HN. Legal, regulatory, and ethical issues in the use of telemedicine. Telemanagement of inflammatory bowel disease 2016; Cham: Springer, 153–177.
Interstate Medical Licensure Compact Commission. Interstate medical licensure compact. XXX; Available at: https://imlcc.org/ (accessed Feb. 17, 2020), in press.
Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46–54.
Bavafa H, Hitt LM, Terwiesch C. The impact of e-visits on visit frequencies and patient health: evidence from primary care. Manage Sci 2018; 64:5461–5480.